Immunohistochemistry (IHC) News and Research

RSS
Immunohistochemistry (IHC) is an imaging technique to visualize antigens in cells. Labeled antibodies bind to target antigens in the cell to image the distribution and localization of specific proteins of interest
Multicolor Immunohistochemistry (IHC): Going Beyond a Single Color

Multicolor Immunohistochemistry (IHC): Going Beyond a Single Color

From Our Bench to Yours: Antibody Advice from Proteintech

From Our Bench to Yours: Antibody Advice from Proteintech

Game-Changers in Western Blotting and Protein Analysis

Game-Changers in Western Blotting and Protein Analysis

AMSBIO expands range of high quality FFPE cancer cell line controls

AMSBIO expands range of high quality FFPE cancer cell line controls

New guideline for HER2 testing in breast cancer benefits patients and clinicians

New guideline for HER2 testing in breast cancer benefits patients and clinicians

Proscia’s new product optimized for digital clinical workflows in anatomic pathology labs

Proscia’s new product optimized for digital clinical workflows in anatomic pathology labs

AMSBIO announces addition of mutation cell line controls to its reference standards

AMSBIO announces addition of mutation cell line controls to its reference standards

NeoGenomics, Definiens expand alliance to develop novel biomarker assays for clinical trials and testing

NeoGenomics, Definiens expand alliance to develop novel biomarker assays for clinical trials and testing

Combinational analysis of FISH and IHC detects NSCLC patients with rare ALK fusions

Combinational analysis of FISH and IHC detects NSCLC patients with rare ALK fusions

PerkinElmer’s Phenoptics solution has potential to predict biomarker for anti-PD1 therapies for Merkel cell carcinoma

PerkinElmer’s Phenoptics solution has potential to predict biomarker for anti-PD1 therapies for Merkel cell carcinoma

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

Researchers reveal potential for exploring new treatment options for triple-negative breast cancer

Researchers reveal potential for exploring new treatment options for triple-negative breast cancer

AMSBIO launches CellMax™ Cell Pellet Slides

AMSBIO launches CellMax™ Cell Pellet Slides

NeoGenomics announces launch of new germline cancer predisposition testing services

NeoGenomics announces launch of new germline cancer predisposition testing services

VENTANA ALK (D5F3) CDx Assay receives FDA approval

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015

Caris Molecular Intelligence allows comparisons between tumors sharing histological features

Caris Molecular Intelligence allows comparisons between tumors sharing histological features

Study findings underscore importance of PD-1/PD-L1 expression in oncogenic signaling pathways

Study findings underscore importance of PD-1/PD-L1 expression in oncogenic signaling pathways

Researchers identify key driver mutations in glioma samples that confirm tumor heterogeneity

Researchers identify key driver mutations in glioma samples that confirm tumor heterogeneity

Study finds difference between results from IHC and quantitative molecular techniques

Study finds difference between results from IHC and quantitative molecular techniques